ArticleFrontiers in pharmacology2024

Oligomeric amyloid-β targeted contrast agent for MRI evaluation of Alzheimer's disease mouse models.

Jang Woo Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.